Partner with Nebu~Flow

We’re seeking partners who share our vision of transforming drug delivery. Our proprietary technology platform enables inhaled delivery of tomorrow’s most exciting biologic therapeutics, to change how life-threatening and life-limiting conditions are treated.

How we can help you achieve your goals

  • A patented technology platform designed to gently aerosolise fragile biologics and other hard-to-nebulise drugs for inhaled delivery.

  • Market exclusivity through new drug-device combinations, with extended protection for the pharma industry.

  • A more efficient and economical route to clinical trials and into the market, due to easier dose adaptation, better data and digital biomarkers that enable smarter trial design.

  • A cost-effective, sustainable solution for drug delivery, through low wastage and eco-friendly design.

  • Deep market research and engagements with healthcare providers, patients and carers.

Technician using laboratory equipment for testing and analysis

Adding IP protection

With five patent families secured for protection through 2040+, Nebu~Flow can provide better and longer term protection for drug-device combination products, than other products on the market.

  • Tailored droplet size for unique drug delivery efficiency

  • Breath actuation

  • Low drug volume

  • Design protection such as RFID tag or key/lock for drug ampule

Nebu~Flow airflow device connected to tubing and system base

Ensuring sustainability

We aim to be a values-driven company, while committing to environmentally responsible manufacturing practices, product innovation and sustainable growth. Our commitments include:

  • Reducing drug wastage to less than 5%

  • Reducing plastic waste through recyclable materials

  • Measuring and comparing baseline emissions

  • Achieving net zero emissions by 2050

Nebu~Flow airflow device connected to tubing and system base

About Nebu~Flow

We’re an ambitious, award-winning med-tech start-up, founded in 2019 and based in Glasgow, UK. We’ve built momentum with high-value pharma collaborations and £11.2m of funding to date. With five patent families secured, prototype devices validated and active engagement with patients, carers and healthcare providers, we’re on course to deliver a more effective, efficient and sustainable platform for tomorrow’s life-changing therapies.

NebuFlow office signage displaying Suite F location

Sign up for our latest news and updates

By signing up you agree to our privacy policy.

© 2026 Acu-Flow Limited (trading as Nebu-Flow®) Registered number: SC624449

Sign up for our latest news and updates

By signing up you agree to our privacy policy.

© 2026 Acu-Flow Limited (trading as Nebu-Flow®) Registered number: SC624449

Sign up for our latest news and updates

By signing up you agree to our privacy policy.

© 2026 Acu-Flow Limited (trading as Nebu-Flow®) Registered number: SC624449

Sign up for our latest news and updates

By signing up you agree to our privacy policy.

© 2026 Acu-Flow Limited (trading as Nebu-Flow®) Registered number: SC624449